Clinical Trial Update: Endostatin Combined With Chemotherapy for Adjuvant Treatment of Esophageal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating endostatin in combination with chemotherapy as adjuvant treatment for esophageal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Endostatin (endostatin)

Snippet

Sponsor: First Affiliated Hospital of Guangxi Medical University | Conditions: Esophageal Cancer | Phase 2 | Status: UNKNOWN